StonvexLoading…
StonvexStonvexStonvexCore line items from GRAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $147.17M | $125.59M | $93.11M | $55.55M |
Operating Income | $-562.16M | $-2.19B | $-1.52B | $-5.44B |
Net Income | $-408.35M | $-2.03B | $-1.47B | $-5.40B |
EPS (Diluted) | $-11.11 | $-63.54 | $-47.21 | $-173.89 |
Total Assets | $2.92B | $2.98B | $3.91B | Not available |
Total Liabilities | $344.15M | $479.90M | $267.63M | Not available |
Cash & Equivalents | $249.73M | $214.23M | $97.29M | $241.60M |
Free Cash Flow OCF − CapEx | $-299.92M | $-582.36M | $-608.69M | $-584.17M |
Shares Outstanding | 36.75M | 33.89M | 0 | 31.05M |